Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
India flag India · Delayed Price · Currency is INR
1,274.45
-5.10 (-0.40%)
Nov 21, 2024, 3:29 PM IST

Suven Pharmaceuticals Revenue

Suven Pharmaceuticals had revenue of 2.58B INR in the quarter ending September 30, 2024, with 11.54% growth. This brings the company's revenue in the last twelve months to 9.61B, down -26.16% year-over-year. In the fiscal year ending March 31, 2024, Suven Pharmaceuticals had annual revenue of 10.51B, down -21.56%.

Revenue (ttm)
9.61B
Revenue Growth
-26.16%
P/S Ratio
33.74
Revenue / Employee
8.06M
Employees
1,193
Market Cap
324.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202410.51B-2.89B-21.56%
Mar 31, 202313.40B201.07M1.52%
Mar 31, 202213.20B3.11B30.75%
Mar 31, 202110.10B1.76B21.10%
Mar 31, 20208.34B-730.13M-8.05%
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition